Insider trades
Ryan Savitz, CFO of Dianthus Therapeutics DNTH, has filed 0 purchases and 11 sales on the open market. Over the past 12 months that comes to a net sale of $11.1M. The latest trade was on 04/09.
Ryan Savitz
EVP, CFO & Cbo
- Company
- Dianthus Therapeutics DNTH
- First filing
- 24/01/26
- Trades
- 26 trades
- Buys / sales
- 0 / 11
- 12-month net buying
- −$11.1M
- Last trade
- 04/09
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale10b5-1 plan | 04/09 | 04/10 | 8,224 sh | $89.84 | $738,844.16 | −100.0% | |
DNTH | Open-market sale10b5-1 plan | 03/31 | 04/01 | 114,367 sh8 trades | $83.00avg. | $9,492,595.5 | −100.0% |
| Open-market sale10b5-1 plan | 25/12/04 | 25/12/05 | 20,000 sh | $45.18 | $903,600 | −100.0% | |
| Open-market sale10b5-1 plan | 25/09/09 | 25/09/11 | 20,000 sh | $35.00 | $700,000 | −100.0% |